Dr. Abhyankar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2330 Shawnee Mission Pkwy
Stop 5003
Westwood, KS 66205Phone+1 913-588-6030Fax+1 913-588-4085
Education & Training
- SUNY Downstate Health Sciences UniversityFellowship, Pediatric Hematology/Oncology, 1987 - 1989
- Seth G.S. Medical CollegeClass of 1981
Certifications & Licensure
- KS State Medical License 2002 - 2025
- MO State Medical License 2000 - 2025
- SC State Medical License 1994 - 2021
- KY State Medical License 1992 - 2001
- NY State Medical License 1999 - 2001
- WI State Medical License 1989 - 1991
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Peripheral Blood Stem Cell (PBSC) Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine Start of enrollment: 2010 Jan 01
- Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
- A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma Start of enrollment: 2010 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsHigh‐level MYC expression associates with poor survival in patients with acute myeloid leukemia and collaborates with overexpressed p53 in leukemic transformation in p...Linlin Gao, Azhar Saeed, Shivani Golem, Da Zhang, Janet Woodroof
International Journal of Laboratory Hematology. 2021-02-01 - 182 citationsLong term disease-free survival in acute leukemia patients recovering with increased γδ T cells after partially mismatched related donor bone marrow transplantationKamar Godder, P. J. Henslee-Downey, Jayesh Mehta, B. S. Park, Kuang-Yueh Chiang
Bone Marrow Transplantation. 2007-06-01 - 88 citationsDual PI3K/AKT/mTOR Inhibitor BEZ235 Synergistically Enhances the Activity of JAK2 Inhibitor against Cultured and Primary Human Myeloproliferative Neoplasm CellsWarren Fiskus, Srdan Verstovsek, Taghi Manshouri, Jacqueline E. Smith, Karissa Peth
Molecular Cancer Therapeutics. 2013-05-01
Journal Articles
- A Phase II/III Randomized, Multicenter Trial of Prednisone /Sirolimus vs Prednisone/Sirolimus/Calcineurin Inhibitor for Treatment of Chronic Graft-Versus-Host Disease:...Amin M Alousi, Mukta Arora, Luciano J Costa, Aleksandr Lazaryan, Daniel J Weisdorf, Sunil Abhyankar, Eneida R Nemecek, Haematologica
Press Mentions
- Cancer Center Is a Contributor to 49 Research Studies at the 62nd American Society of Hematology Annual MeetingDecember 4th, 2020
- Overland Park Bone Marrow Transplant Recipient Meets Donor in New YorkFebruary 21st, 2020
- Optimizing the Immune System to Beat CancerJune 1st, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: